(Q36824545)

16 August 2017

1 reference

title

Clinical aspects of systemic sclerosis (scleroderma) (English)

1 reference

https://api.crossref.org/works/10.1136/ARD.50.SUPPL_4.854

15 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750797

15 November 2022

1 reference

https://api.crossref.org/works/10.1136/ARD.50.SUPPL_4.854

15 November 2022

1 reference

https://api.crossref.org/works/10.1136/ARD.50.SUPPL_4.854

15 November 2022

author name string

R. M. Silver

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750797

15 November 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

PMC publication ID

1033320

full work available at URL

16 August 2017

https://europepmc.org/articles/PMC1033320

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750797

https://europepmc.org/articles/PMC1033320?pdf=render

15 November 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1750797

https://syndication.highwire.org/content/doi/10.1136/ard.50.Suppl_4.854

15 November 2022

1 reference

https://api.crossref.org/works/10.1136/ARD.50.SUPPL_4.854

Annals of the Rheumatic Diseases

15 November 2022

published in

1 reference

16 August 2017

50 Suppl 4

1 reference

16 August 2017

854-861

1 reference

A prospective study of Raynaud phenomenon and early connective tissue disease. A five-year report

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Factors predicting development of renal involvement in progressive systemic sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Connective tissue synthesis by scleroderma skin fibroblasts in cell culture

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Autoantibodies in childhood scleroderma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Scleroderma and scleroderma-like disorders

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Diagnosis of Raynaud's phenomenon assisted by color charts

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Does Sc1-70 modulate collagen production in systemic sclerosis?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Normotensive renal failure in systemic sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Eosinophilic fasciitis in children

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Progressive systemic sclerosis sine scleroderma presenting as pulmonary interstitial fibrosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

The diagnostic value of several immunological tests for anti-nuclear antibody in predicting the development of connective tissue disease in patients presenting with Raynaud's phenomenon

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Autoantibody to RNA polymerase I in scleroderma sera

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

The relevance of elevated Borrelia burgdorferi titres in localized scleroderma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Evidence for spirochetal origin of circumscribed scleroderma (morphea).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1033320

Family studies in scleroderma (systemic sclerosis) demonstrating an HLA-linked increased chromosomal breakage rate in cultured lymphocytes

5 September 2018

1 reference

12 December 2020

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

1 reference

12 December 2020

Association between fluorescent antinuclear antibodies, capillary patterns, and clinical features in scleroderma spectrum disorders

1 reference

12 December 2020

Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril

1 reference

12 December 2020

HLA antigens, autoantibodies and clinical subsets in scleroderma

1 reference

12 December 2020

Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage

1 reference

12 December 2020

Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma

1 reference

12 December 2020

Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis

1 reference

12 December 2020

Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities

1 reference

12 December 2020

Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis

1 reference

12 December 2020

How to classify Raynaud's phenomenon. Long-term follow-up study of 73 cases

1 reference

12 December 2020

Elevated pro alpha 2(I) collagen mRNA levels in cultured scleroderma fibroblasts result from an increased transcription rate of the corresponding gene

1 reference

12 December 2020

Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis

1 reference

12 December 2020

Interstitial lung disease in scleroderma. Immune complexes in sera and bronchoalveolar lavage fluid

1 reference

12 December 2020

Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis

1 reference

12 December 2020

Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis

1 reference

12 December 2020

Antinuclear antibodies in the relatives of patients with systemic sclerosis

1 reference

12 December 2020

Increased dermal mast cell populations in progressive systemic sclerosis: a link in chronic fibrosis?

1 reference

12 December 2020

Pulmonary disease associated with L-tryptophan-induced eosinophilic myalgia syndrome. Clinical and pathologic features

1 reference

12 December 2020

Evaluation and management of scleroderma lung disease using bronchoalveolar lavage

1 reference

12 December 2020

Ketotifen prevents skin fibrosis in the tight skin mouse

1 reference

12 December 2020

Continuous ambulatory peritoneal dialysis in scleroderma

1 reference

12 December 2020

Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride

1 reference

12 December 2020

Lung Involvement in Scleroderma

1 reference

12 December 2020

TGF-beta inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression

1 reference

12 December 2020

Activation of the complement system in systemic sclerosis. Relationship to clinical severity

1 reference

12 December 2020

Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance

1 reference

12 December 2020

Effect of lymphotoxin and tumor necrosis factor on endothelial and connective tissue cell growth and function

1 reference

12 December 2020

High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients

1 reference

12 December 2020

Inhibition of fibrosis in TSK mice by blocking mast cell degranulation

1 reference

12 December 2020

Exocrine pancreatic function in patients with progressive systemic sclerosis

1 reference

12 December 2020

Antinuclear antibodies in localized scleroderma: unique staining in chromosome spreads

1 reference

12 December 2020

Pulmonary arterial histology and morphometry in systemic sclerosis: a case-control autopsy study

1 reference

12 December 2020

Oesophageal motility and lower oesophageal sphincter competence in progressive systemic sclerosis and localized scleroderma

1 reference

12 December 2020

Borrelia burgdorferi and localized scleroderma

1 reference

12 December 2020

Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity

1 reference

12 December 2020

Prospective study of the evolution of Raynaud's phenomenon

1 reference

12 December 2020

Familial clustering of scleroderma spectrum disease

1 reference

12 December 2020

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon

1 reference

12 December 2020

Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis

1 reference

12 December 2020

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

12

1 reference

https://api.crossref.org/works/10.1136/ARD.50.SUPPL_4.854

The changing face of severe scleroderma in five patients

15 November 2022

30

1 reference

https://api.crossref.org/works/10.1136/ARD.50.SUPPL_4.854

Reduced coronary flow and resistance reserve in primary scleroderma myocardial disease.

15 November 2022

36

1 reference

https://api.crossref.org/works/10.1136/ARD.50.SUPPL_4.854

15 November 2022

Identifiers

1 reference

16 August 2017

1 reference

PMC publication ID

1033320

16 August 2017

1 reference

PMC publication ID

1033320